ArrowArtboardCreated with Sketch.Title ChevronTitle ChevronIcon FacebookIcon LinkedinIcon Mail ContactPath LayerIcon MailPositive ArrowIcon PrintIcon Twitter
Coronavirus

Australian PM gets COVID vaccine in 'massive step' toward normal

Morrison among small group receiving the country's first round of Pfizer shot

Australian Prime Minister Scott Morrison has introduced some of the strictest community mobility restrictions in the world to manage the spread of the virus.   © Reuters

SYDNEY (Reuters) -- Australian Prime Minister Scott Morrison received the first dose of a COVID-19 vaccine on Sunday, calling the start of the nation's vaccination programme a "massive step" that will enable it to return to normal.

Up to 4 million Australians are expected to be inoculated by March, with Morrison among a small group receiving the first round of the Pfizer/BioNTech vaccine.

"This is the beginning of a big game change," Morrison told reporters moments after getting injected at a medical centre in Sydney. "Every day that goes past from here gets more normal. And that is what is exciting about today."

The intergovernmental National Cabinet is to review how its five-stage vaccination programme will change the way the country manages the risk of coronavirus transmission in the future, including at its state and international borders.

Australian states have introduced some of the strictest community mobility restrictions in the world to manage the spread of the virus, including intermittent city lockdowns, curfews and border closures.

Reporting a second consecutive day with no coronavirus transmission in the community, the nation has had just under 29,000 infections and 909 deaths since March, ranking among the top 10 in a COVID-19 performance index.

Morrison said the vaccine addresses his "greatest fear" as prime minister: "serious disease and the sort of widespread fatalities that we saw overseas."

A small number of older Australians at the Castle Hill Medical Centre in western Sydney, aged-care staff, and frontline nurses and workers were also among the first injected, officials said.

From Monday morning, a broader "phase 1-A" rollout is to begin among aged-care and disability staff, and border protection and quarantine workers at vaccine hubs nationwide.

"Phase 1-B" vaccinations of immunocompromised people and those over 70 years old, as well as Indigenous Australians over 55 years old and emergency service workers, are to follow.

The vast majority of the population will be injected with the AstraZeneca vaccine, which can be produced locally, by the end of October.

On Saturday, thousands of people attended anti-vaccine rallies in major Australian cities to protest what they incorrectly believed to be mandatory vaccinations.

Sponsored Content

About Sponsored Content This content was commissioned by Nikkei's Global Business Bureau.

You have {{numberArticlesLeft}} free article{{numberArticlesLeft-plural}} left this monthThis is your last free article this month

Stay ahead with our exclusives on Asia;
the most dynamic market in the world.

Stay ahead with our exclusives on Asia

Get trusted insights from experts within Asia itself.

Get trusted insights from experts
within Asia itself.

Try 1 month for $0.99

You have {{numberArticlesLeft}} free article{{numberArticlesLeft-plural}} left this month

This is your last free article this month

Stay ahead with our exclusives on Asia; the most
dynamic market in the world
.

Get trusted insights from experts
within Asia itself.

Try 3 months for $9

Offer ends October 31st

Your trial period has expired

You need a subscription to...

  • Read all stories with unlimited access
  • Use our mobile and tablet apps
See all offers and subscribe

Your full access to Nikkei Asia has expired

You need a subscription to:

  • Read all stories with unlimited access
  • Use our mobile and tablet apps
See all offers
NAR on print phone, device, and tablet media

Nikkei Asian Review, now known as Nikkei Asia, will be the voice of the Asian Century.

Celebrate our next chapter
Free access for everyone - Sep. 30

Find out more